Table 7.
Effect of vaccines on IC c hallenge with WNV in CD8−/− mice
Vaccination | Challenge Dose WNV PFU | # survived/total | P value |
---|---|---|---|
Challenge: Day 60, no boost | |||
Placebo | 101 | 0/10 | |
DNA plasmid | 101 | 1/10 | 0.2 |
Inactivated WNV | 101 | 4/10 | < 0.001 |
Challenge: Day 70, one boost | |||
Placebo | 101 | 0/10 | |
DNA plasmid | 101 | 4/10 | 0.005 |
Inactivated WNV | 101 | 8/10 | < 0.0005 |
CD8−/− mice were vaccinated DNA plasmid, formalin-inactivated WNV New York, and placebo vaccines. Mice were challenge after primary immunization at day 60 or ten days after a boost, at day 70 with either 101 PFU of WNV by an IC route and monitored for survival for 28 days. P values were determined using the log rank test.